4 Healthcare Stock Stories for Investment Wellness

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Biolase (NASDAQ:BIOL): Closing price $3.37

The maker and distributor of dental lasers Biolase reported Wednesday that the FDA has approved the 940nm Diolase 10 diode soft tissue laser for use in 19 additional medical markets, including arthroscopy, ear, nose and throat; oral surgery, gastroenterology, general surgery, dermatology, plastic surgery, podiatry, GI/GU, gynecology, neurosurgery, ophthalmology, pulmonary surgery, cardiac surgery, thoracic surgery, urology, dermatology, aesthetics, and vascular surgery. This FDA clearance includes more than 80 different procedures.

biol

 

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business